Skip to content
  1. Home
  2. Medications & hormones
  3. Methandienone (Dianabol)

Methandienone (Dianabol)

An anabolic steroid whose FDA approval was revoked in 1985 and is no longer approved for human use.

Medications & hormones

Research records

Historical source snapshot. Not freshly verified, not a recommendation. Study findings, community accounts and app defaults are not interchangeable.

Publication suitability · 2026-10-15: Historical reference only; not a clinical verification. Clinical, regulatory, efficacy, safety and dose claims are not independently established by this review.

Methandienone (Dianabol)

An anabolic steroid whose FDA approval was revoked in 1985 and is no longer approved for human use.

Evidence category: Reference only. This describes the source category, not approval or certainty.

Regulatory statement in source: FDA approval revoked in 1985.

Methandienone (Dianabol) is an orally active synthetic anabolic steroid. The FDA accepted it as 'Probably Effective' in 1970 for post-menopausal osteoporosis and pituitary-deficient dwarfism. However, CIBA withdrew it from the U.S. market in 1983 and the FDA revoked its approval entirely in 1985. It is no longer approved for human use.

Benefits reported in the imported source

  • Historical regulatory approval (revoked) for osteoporosis and dwarfism

Risks and limits

  • FDA approval revoked in 1985
  • Hepatotoxicity
  • Lipid abnormalities
  • Virilization in women

Source bottom line: No longer FDA-approved; regulatory approval was revoked in 1985 despite historical acceptance for specific conditions.

Uncertainty: Reference information only. Not medical advice.

Study protocols — reports, not instructions

No study protocol recorded in this snapshot. This does not establish that no study exists.

Community and practice descriptions

Accounts of a practice are not evidence of safety or effectiveness. Words such as “standard”, “safe” or “recommended” describe the source account, not verified consensus or this wiki’s advice. Commercial and self-published citations are retained for traceability, not vendor endorsement or independent clinical corroboration.

Pharmacokinetic context

Historical half-life estimate: 3–6 hours. Llewellyn, Anabolics (2011); Ruiz & Strain, Lowinson and Ruiz's Substance Abuse (2011), p.358 — compiled pharmacology references Population/route context and estimates may differ. This is not a schedule or a verified human dosing rule.

Source references

Snapshot provenance

Source ID: catalog:hormone:methandienone. Commit: adc7684614f9439b41d91a3312b62e7982c7e20e. Review state: historical-not-reverified. Authored links are retained separately from the canonical evidence links in the public data. App templates/defaults and rejected drafts are archived, not deployed.

Related entries and components

None listed.